Abstract
Numerous drugs prolong the QT interval, and drug-induced QT prolongation is a frequently encountered situation in hospital settings. QT prolongation increases the risk of Torsades de Pointes (TdP), which can be life-threatening. A 70-year-old female with a history of atrial flutter post ablation and ischemic heart disease was admitted for shortness of breath and found to be in atrial flutter with variable atrioventricular block. She was treated with intravenous amiodarone, digoxin loading dose, beta-blockers, and diuretics. The patient converted to sinus rhythm but developed QT prolongation and TdP secondary to amiodarone. The drug was discontinued. After ruling out active ischemia, a diagnosis of idiosyncratic amiodarone-induced TdP was made. Although the incidence of TdP due to amiodarone use is rare, idiosyncratic amiodarone-induced TdP can occur secondary to long QT syndrome or polymorphisms. The treatment includes holding the drug, administration of magnesium sulfate, replenishment of all electrolytes, and cardioversion if needed. Although amiodarone is considered a low-risk drug for precipitating TdP, risk factors including older age, female sex, ischemic heart disease, and electrolyte abnormalities are essential considerations. Drug-induced TdP can be life-threatening due to its potential to degenerate into ventricular fibrillation. Prompt recognition, discontinuation of the drug, and empiric administration of magnesium sulfate are essential.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
Abbreviations
- TdP:
-
Torsades de Pointes
- AV:
-
Atrioventricular
- NSVT:
-
Nonsustained polymorphic ventricular tachycardia
- PVC:
-
Premature ventricular contraction
- LAD:
-
Left anterior descending artery
- VT:
-
Ventricular tachycardia
References
Punnam SR, Goyal SK, Kotaru VP, Pachika AR, Abela GS, Thakur RK. Amiodarone - a “broad spectrum” antiarrhythmic drug. Cardiovasc Hematol Disord-Drug Targets. 2010;10(1):73–81.
Freedman MD, Somberg JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991;31(11):1061–9.
Shenthar J, Rachaiah JM, Pillai V, Chakali SS, Balasubramanian V, Chollenhalli NM. Incidence of drug-induced Torsades de Pointes with intravenous amiodarone. Indian Heart J. 2017;69(6):707–13.
Baldzizhar A, Manuylova E, Marchenko R, Kryvalap Y, Carey MG. Ventricular tachycardias. Crit Care Nurs Clin North Am. 2016;28(3):317–29.
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013–22.
Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of Torsade de Pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047–60.
Antzelevitch C. Role of transmural dispersion of repolarization in the genesis of drug-induced Torsades de Pointes. Heart Rhythm. 2005;2(2 Suppl):S9-15.
Mason JW, Hondeghem LM, Katzung BG. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res. 1984;55(3):278–85.
Tester DJ, Will ML, Haglund CM, Ackerman MJ. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47(4):764–8.
Takahashi K, Yamashita M, Sakaue T, Enomoto D, Uemura S, Okura T, et al. Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy. Ann Noninvasive Electrocardiol. 2021;26(6):e12842.
Author information
Authors and Affiliations
Contributions
HK: conceptualization and write-up; GM: review of literature and manuscript preparation; AA: review of literature and manuscript preparation; MN: review of literature and manuscript preparation; MJ: supervision and manuscript write-up.
Corresponding author
Ethics declarations
Ethical Approval
Not applicable.
Consent to Participate
Not applicable.
Written Consent for Publication
Written informed consent was obtained from the patient.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Khandait, H., Musleh, G., Abruzzo, A. et al. Idiosyncratic Amiodarone-Induced Torsades de Pointes: A Case Report. SN Compr. Clin. Med. 6, 40 (2024). https://doi.org/10.1007/s42399-024-01677-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-024-01677-3